Form 4 for ZBH Zimmer Biomet
Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-10 · accession 0001062993-22-007442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-11 | 2022-03-10 | ZBH | Winkler Lori | SVP, CHRO | F - Tax | $123.08 | -65 | 231 | -22% | -$8,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | F | D | 65 | $123.08 | 231 | D | — | — | (F1) Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units. (F2) Holdings reflect the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. On March 4, 2022, the reporting person reported the acquisition of 181 shares upon the vesting of restricted stock units on March 2, 2022, which did not yet reflect certain adjustments made to outstanding equity awards effective March 1, 2022 in connection with the spinoff to preserve the intrinsic value of such awards, because the exchange ratio to be used for such adjustments had not yet been determined. Subsequently, the exchange ratio calculation was completed, and the 181 shares were adjusted to 187 shares, which is now reflected in the reporting person's total holdings. |